An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study Provided by ACCESS Newswire Jul 28, 2025, 1:25:00 PM ...

Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs.

Today's biotech news covers a surge in counterfeit weight loss drugs, sprawling effects of proposed NIH cuts, and more.

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor ...

However, with 38% of GLP-1 users indicating a decrease in dining out–double the percentage of those who indicated an increase (19%)–understanding which restaurants are still attracting those on weight ...

While Nysos paid $2.20 bto win the $300,000 San Diego Handicap, 18-1 longshot Lovesick Blues paid $39.20 for his 1¾-length win over Baffert’s Hejazi (Juan Hernandez) in the Crosby.

As of right now, the Vancouver Canucks have a decent amount of cap space available. And if they play their cards right – and in the same general way they’ve played them in recent years ...

A recent study found that tumors in mice shrank after they were administered tirzepatide. It could take years for GLP-1 drugs to obtain regulatory approval as cancer-related treatments.

Glassnode says bitcoin has surpassed $1 trillion in realized cap for the first time, highlighting deep liquidity, macro relevance and continued institutional demand.

As more research is done on GLP-1 drugs, the number of indications they can treat may grow significantly. And if tirzepatide is able to help treat cancer, it could make this already massive drug a ...